ORIGINAL RESEARCH
Accepted on 26 Mar 2025
Establishment of a nomogram based on Lasso Cox regression for albumin combined with systemic immuneinflammation index score to predict prognosis in advanced pancreatic carcinoma
doi 10.3389/fonc.2025.1447055
- Frontiers in Oncology
- Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
- Research Topics
- The Growing Role of Immunotherapy and Combination Strategies in Pancreatic and Hepatobiliary Cancers
The Growing Role of Immunotherapy and Combination Strategies in Pancreatic and Hepatobiliary Cancers
2,857
Total downloads
9,956
Total views and downloads
Articles
SYSTEMATIC REVIEW
Published on 12 Feb 2025
Enhanced antitumor activity of combined hepatic arterial infusion chemotherapy with Lenvatinib and PD-1 inhibitors in unresectable hepatocellular carcinoma: a meta-analysis
doi 10.3389/fonc.2025.1513394
- 546 views
ORIGINAL RESEARCH
Published on 05 Feb 2025
Efficacy and safety of immune checkpoint inhibitors in patients with advanced intrahepatic cholangiocarcinoma
doi 10.3389/fonc.2025.1498887
- 398 views
CASE REPORT
Published on 29 Jan 2025
Case report: PD-L1-targeted high-affinity natural killer cells and IL-15 superagonist N-803-based therapy extend overall survival of advanced metastatic pancreatic cancer patients
doi 10.3389/fonc.2025.1472714
- 1,366 views
CASE REPORT
Published on 17 Dec 2024
Case report: Achieving significant tumor reduction in advanced pancreatic adenocarcinoma
doi 10.3389/fonc.2024.1458517
- 596 views
ORIGINAL RESEARCH
Published on 11 Dec 2024
Prolonged survival by combination treatment with a standardized herbal extract from Japanese Kampo-medicine (Juzentaihoto) and gemcitabine in an orthotopic transplantation pancreatic cancer model
doi 10.3389/fonc.2024.1454291
- 906 views
SYSTEMATIC REVIEW
Published on 11 Dec 2024
Prognostic role of systemic inflammation response index (SIRI) in patients with pancreatic cancer: a meta-analysis
doi 10.3389/fonc.2024.1465279
- 570 views
ORIGINAL RESEARCH
Published on 02 Dec 2024
Sorafenib combined with tarexib for first-line treatment of unresectable hepatocellular carcinoma and its predictive role and correlation with PD-L1 CTCs
doi 10.3389/fonc.2024.1478596
- 536 views
CASE REPORT
Published on 24 Oct 2024
Case report: Combinations of immune checkpoint inhibitor, chemotherapy, and hyperthermia therapy avoid lymphatic recurrence in cholangiocarcinoma
doi 10.3389/fonc.2024.1421340
- 739 views
SYSTEMATIC REVIEW
Published on 17 Oct 2024
Evaluating the benefits of adjuvant chemotherapy in patients with pancreatic cancer undergoing radical pancreatectomy after neoadjuvant therapy—a systematic review and meta-analysis
doi 10.3389/fonc.2024.1429386
- 825 views
CASE REPORT
Published on 15 Jul 2024
Case report: Translational treatment of unresectable intrahepatic cholangiocarcinoma: Tislelizumab, Lenvatinib, and GEMOX in one case
doi 10.3389/fonc.2024.1428370
- 896 views
- 3 citations
